Navigation Links
Wound Management Technologies, Inc. Announces FDA Clearance of 510k

FORT WORTH, Texas, Nov. 13 /PRNewswire-FirstCall/ -- Wound Care Innovations, LLC, a subsidiary of Wound Management Technologies, Inc., (OTC Bulletin Board: WNDM), announced today the 510k clearance of a new wound management product utilizing their patented hydrolyzed collagen technology.

The new addition to our product line (patent pending) combines hydrolyzed collagen with the healing properties of polysulfated glycosaminoglycan (PSGAG) and will initially be available in gel form. PSGAG enhances the absorptive capacity of the hydrolyzed collagen gel, making it appropriate for the management of exudative wounds. In addition, PSGAG has been shown to prepare the granulation tissue for epidermal migration by maintaining a uniform, low density granulation tissue more easily modified by the migrating epithelium thus improving the rate of epithelialization of a chronic wound and reducing scarring.

The product has been cleared and is indicated for topical use in the management of chronic and acute wounds and dermal ulcers including the management of:
-- Pressure Ulcers (Stages I-IV)

-- Venous Stasis Ulcers

-- Diabetic Ulcers

-- First and Second Degree Burns

-- Surgical Wounds

-- Traumatic wounds

-- Superficial Wounds

-- Ulcers resulting from arterial insufficiency

-- Grafted wounds and donor sites

"We are delighted with the FDA clearance of the hydrolyzed collagen with polysulfated glycosaminoglycan (PSGAG)," states Cathy Bradshaw, President of Wound Care Innovations. "This allows us to bring to the high margin, advanced wound care market, a product that utilizes our proven, patented hydrolyzed collagen and incorporates the distinctive characteristics of PSGAG to prepare the wound bed for re-epithelialization, wound closure."

Costs associated with wound care are significant, exceeding billions of dollars annually. "We are introducing a new, improved product which addresses the epithelialization of healing wounds and will be cost effective, patient ready and easy to use in all health care settings. The product is cost effective both in terms of direct and indirect costs. We are encouraged by initial test observations which promise improved clinical outcomes for the patient. Our expectations are high. We expect our hydrolyzed collagen with Polysulfated Glycosaminoglycan to contribute significantly to our growth moving forward."

About Wound Management Technologies, Inc.:

Wound Management Technologies, Inc. (OTC Bulletin Board: WNDM), with its corporate headquarters in Fort Worth, Texas, markets and distributes wound care products to the healthcare market under patented technology licensed to the Company. The Company is positioned and seeks to be a leading provider of wound care products. For more information on the Company please visit the Company's Website at .

"Safe Harbor" Statement: Under The Private Securities Litigation Reform Act of 1995: The statements in the press release that relate to the company's expectations with regard to the future impact on the company's results from new products in development are "forward-looking statements," within the meaning of the Private Securities Litigation Reform Act of 1995. Since this information may contain statements that involve risk and uncertainties and are subject to change at any time, the company's actual results may differ materially from expected results. This document may contain forward-looking statements concerning the Company's operations, current and future performance and financial condition. These items involve risks and uncertainties such as product demand, market and customer acceptance, the effect of economic conditions, competition, pricing, the ability to consummate and integrate acquisitions, and other risks and uncertainties detailed in the Company's SEC filings. The Company undertakes no obligation to revise any of these statements to reflect the future circumstances or the occurrence of unanticipated events.

For Further Information:

Product Information Shareholder Relations

Cathy Bradshaw Lucy Singleton

President Secretary

954-315-9242 817-820-7080

SOURCE Wound Management Technologies, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. Easter Seals Awarded $100,000 McCormick Foundation Grant to Help Employ Wounded Veterans
2. New Web Site Offers Shirts with Custom-embroidered Aviator Wings for Veteran Military Pilots, Supports Families of the Wounded Fund
3. Penn State Program To Help Wounded Warriors
4. ULURU Inc. Hosts Symposium on Altrazeal(TM) at the 23rd Annual Clinical Symposium on Advances in Skin & Wound Care
5. Wound Management Technologies, Inc. Announces Strategic Business Directions, Recent Conference Presentation, in Addition to Symposium Exhibit Plans for Las Vegas
6. ConvaTec Names Presidents of Wound Therapeutics and Ostomy Care Business Units
7. ULURU Inc. Announces Poster Presentations at the 23rd Annual Clinical Symposium on Advances in Skin & Wound Care
8. Livelihood Programs Help Heal War Wounds in Uganda
9. VA, DoD Electronically Hand Off Records of Wounded Patients
10. Wound Management Technologies, Inc. Announces Strategic Plans for Revenue Growth for Year End and 2009
11. Association for the Advancement of Wound Care Leads World Health Organization Initiative to Establish Guidelines for Wound and Lymphedema Care
Post Your Comments:
(Date:11/26/2015)... ... November 26, 2015 , ... Patients at Serenity Point ... come together on Thanksgiving Day to share the things that they are most ... Serenity Point YouTube channel, patients displayed what they wrote on index cards, describing ...
(Date:11/26/2015)... ... ... Inevitably when people think Thanksgiving, they also think Holiday sales and start ... and Cyber Monday massage chair sales to receive the best pricing on ... find the best massage chair deals, they can see all of the coupons in ...
(Date:11/26/2015)... Toronto, ON and Cambridge, ON (PRWEB) , ... ... ... announced today the availability of a real-time eReferral system for diagnostic imaging in ... CTs, ultrasounds, X-rays, mammography, BMD and Nuclear Medicine tests directly from their electronic ...
(Date:11/26/2015)... ... November 26, 2015 , ... ... Representative. As a franchise owner, Somu now offers travelers, value and care based ... packages, private cruise sales, as well as, cabin upgrades and special amenities such ...
(Date:11/26/2015)... ... November 26, 2015 , ... The Catalent Applied Drug ... need to integrate dose form selection in early phase drug development. The first ... supporting and bringing together the UK’s emerging life sciences companies, corporate partners, and ...
Breaking Medicine News(10 mins):
(Date:11/26/2015)... , Países Bajos, November 26, 2015 ... terapia fotodinámica de Bremachlorin para el cáncer avanzado. ... inmunoterapia con la terapia fotodinámica de Bremachlorin para el ... nuevo enfoque combina la inmunoterapia con la terapia fotodinámica ... Clinical Cancer Research . --> Clinical ...
(Date:11/26/2015)... 26 november 2015 AAIPharma Services ... geplande investering aan van ten minste $15,8 ... en het mondiale hoofdkantoor in ... resulteren in extra kantoorruimte en extra capaciteit ... groeiende behoeften van de farmaceutische en biotechnologische ...
(Date:11/26/2015)... , November 26, 2015 ... A new combination approach blends immunotherapy with Bremachlorin-photodynamic therapy ... new combination approach blends immunotherapy with Bremachlorin-photodynamic therapy for ... new combination approach blends immunotherapy with Bremachlorin-photodynamic therapy for ... has found that immunotherapy can be efficiently ...
Breaking Medicine Technology: